A
We are trying to standardise our procedures for our offices in each country when they return used medical devices to us (as the manufacturer) for complaint investigation.
In the USA we have decided to base our procedure on § 173.199(d) - as outlined in http://hazmat.dot.gov/training/rmgmt/InfectSubstances.pdf. This seems to avoid shipping as dangerous goods.
Does anyone else have any experience in setting a global procedure? Am I heading in the right direction with the document quoted above?
Thanks for your feedback.
Regards
In the USA we have decided to base our procedure on § 173.199(d) - as outlined in http://hazmat.dot.gov/training/rmgmt/InfectSubstances.pdf. This seems to avoid shipping as dangerous goods.
Does anyone else have any experience in setting a global procedure? Am I heading in the right direction with the document quoted above?
Thanks for your feedback.
Regards
Attachments
-
1.5 MB Views: 241